A recent study known as the BIG D-FOOT, which was randomised, double-blinded and controlled, revealed that employing local antibiotic delivery through STIMULAN® leads to a notable decrease in post-surgical infective issues among patients dealing with diabetic foot osteomyelitis (DFO). This treatment approach has shown to significantly reduce the chances of complications following the surgical procedure. In an effort to delve into the best practices for treating individuals with this condition, a symposium by Biocomposites is set to explore this topic and share insights. This study signifies a breakthrough as it presents a promising solution in reducing infective complications associated with DFO in patients.